Journals / European Journal of Rheumatology / 2014 / Cilt: 1 - Sayı: 4

Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance

Pages
135–139
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

IL-18 may be a marker for early evaluation of atherosclerosis in RA patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Plasma interleukin-18 (IL-18) has been reported to be associated with homeostasis model assessment of insulin resistance (HOMAIR).
📊
Key Findings & Data:Parameters of systemic inflammation are also significantly associated with circulating IL-18.
💡
Conclusion & Impact:IL-18 may be a marker for early evaluation of atherosclerosis in RA patients
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Plasma interleukin-18 (IL-18) has been reported to be associated with homeostasis model assessment of insulin resistance (HOMAIR). It also has been described as one of the factors that, in addition to insulin resistance, may also contribute to atherosclerosis. Parameters of systemic inflammation are also significantly associated with circulating IL-18. Our objective was to investigate whether IL-18 is associated with insulin resistance and atherosclerosis in patients with rheumatoid arthritis (RA) in which accelerated atherogenesis develops.Material and Methods: Fifty-one female RA patients and 30 female controls were enrolled in the study; 31 of them were without diseasemodifying antirheumatic drug (DMARD) treatment and had a relatively short disease duration. Disease activity was assessed by Disease Activity Score (DAS) 28 index. HOMA-IR method was used to detect insulin resistance. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), fasting plasma glucose (FPG), insulin, tumor necrosis factor alpha (TNF-?), and IL-18 levels were evaluated. Also, carotid intima-media thickness (cIMT) was measured.Results: There were no differences between patients and the control group according to age, sex, and body mass index. ESR, CRP, insulin, FPG, HOMA-IR, TNF-?, IL-18 levels, and cIMT measurements were significantly high in the patient group. HOMA-IR and cIMT measurements were similar and high in both the DMARD and non-DMARD patient groups. HOMA-IR correlated with TNF-? (r=0.308, p=0.028), but no correlation was found between IL-18 and HOMA-IR. However, IL-18 was correlated positively with cIMT (r= 0.318, p=0.028) and negatively with BMI (r=-0.360, p=0.01).Conclusion: IL-18 is associated with atherosclerosis in RA patients. However, no significant relation was found with insulin resistance. IL-18 may be a marker for early evaluation of atherosclerosis in RA patients

🔖

Cite This Article

AKIN, Ş., UGAN, Y., SÜTÇÜ, R., KUTLUCAN, A., KÖROĞLU, B., TUNÇ, Ş. E., ŞAHİN, M., KILBAŞ, A., YEŞİLDAĞ, A. (2022). Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance. European Journal of Rheumatology, Cilt: 1 - Sayı: 4, 135–139. https://ajindex.com/articles/511848

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003
  2. [CrossRef] Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid ar- thritis. Arthritis Rheum 1994
  3. [CrossRef] del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort no ex- plained by traditional cardiac risk factors. Arthri- tis Rheum 2001
  4. [CrossRef] Ross R. Atherosclerosis: an inflammatory dis- ease. N Engl J Med 1999
  5. [CrossRef] Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002
  6. [CrossRef] Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997
  7. [CrossRef] Ridker PM, Buring JE, Shih J, Matias M, Hen- nekens CH. Prospective study of C-reactive pro- tein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998
  8. [CrossRef] Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000
  9. [CrossRef] Park YB, Choi HK, Lee SH, In BH, Lee HC, Nam CM et al. Atherosclerosis in rheumatoid arthritis: morpho- logic evidence obtained by carotid ultrasound. Ar- thritis Rheum 2003
  10. [CrossRef] McInnes IB, Gracie JA, Liew FY. Interleukin-18: a novel cytokine in inflammatory rheumatic dis- ease. Arthritis Rheum 2001
  11. [CrossRef] Liew FY. The role of innate cytokines in inflam- matory response. Immunology Letters 2003
  12. [CrossRef] Gracie AJ, Forsey JR, Ling Chan W, Gilmour A, Leung PB, Greer RM, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin In- vest 1999
  13. [CrossRef] Mallat Z, Corbaz A, Scoazec A, Besnard S, Lese- che G, Chvatchko Y, Tedgui A. Expression of in- terleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001
  14. [CrossRef] Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma